TRUP

Trupanion, Inc. · NASDAQ

Sector Finance
Industry Multi-Line Insurance
Website rupanion.com
Employees(FY) 1187
ISIN US8982021060

Performance

-2.55%

-3.74%

-14.62%

+25.93%

-2.37%

YTD

+73.01%

Profile

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.

Advanced Technical Analysis

Technical Analysis of TRUP 2025-01-31

The stock indicators reflect a bearish sentiment, with the Moving Average Score at 33, Oscillators Score at 43, and a Technical Score of 36, indicating overall weakness in price momentum and suggesting caution for potential investors. The scores collectively point to a lack of bullish signals, reinforcing a negative outlook for the stock.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of TRUP

Stock Rank

Recent News & Updates

2025-01-28 19:00
DXCM: Raising target price to $51.00(Argus Research)
2025-01-23 14:35
Trupanion Shares Rise After Upgrade From Piper Sandler(MT Newswires)
2025-01-23 09:00
Trupanion, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release and Conference Call(GlobeNewswire)
2025-01-23 07:20
Piper Sandler Upgrades Trupanion to Overweight From Neutral, $57 Price Target(MT Newswires)
2025-01-22 20:00
Trupanion, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release and Conference Call(Globenewswire)
2025-01-21 19:00
TRUP: Raising target price to $50.00(Argus Research)
2025-01-21 19:00
DXCM: Raising target price to $50.00(Argus Research)
2025-01-14 19:00
DXCM: Lowering target price to $46.00(Argus Research)
2025-01-14 19:00
TRUP: Lowering target price to $46.00(Argus Research)
2025-01-07 19:00
TRUP: Lowering target price to $50.00(Argus Research)
2025-01-07 12:00
Trupanion (TRUP) Upgraded to Strong Buy: Here's Why(Zacks)
2025-01-07 08:00
Trupanion Named Best Place to Work in 2025(GlobeNewswire)
2025-01-06 19:00
Trupanion Named Best Place to Work in 2025(Globenewswire)
2024-12-31 10:00
Best Momentum Stocks to Buy for December 31st(Zacks)
2024-12-30 19:00
DXCM: Lowering target price to $51.00(Argus Research)
2024-12-27 09:05
Zacks Industry Outlook Highlights Aflac Incorporated, Unum Group, Trupanion, and Employers Holdings(Zacks)
2024-12-26 09:34
4 Accident & Health Insurance Stocks to Watch as Exposure Increases(Zacks)
2024-12-23 19:00
DXCM: Lowering target price to $52.00(Argus Research)
2024-12-17 19:00
DXCM: Lowering target price to $56.00(Argus Research)
2024-12-17 15:56
Trupanion Collaborates With URvet Care to Simplify Veterinary Payments(MT Newswires)
2024-12-17 14:58
URvet Care Taps Trupanion to Offer Seamless Payment Solution for Veterinary Care(PR Newswire)
2024-12-17 01:58
URvet Care Taps Trupanion to Offer Seamless Payment Solution for Veterinary Care(Prnewswire)
2024-12-13 05:25
Trupanion (NASDAQ:TRUP) adds US$77m to market cap in the past 7 days, though investors from three years ago are still down 56%(Simply Wall St.)
2024-12-11 08:00
Trupanion Named Top Employer in Six Categories at VIBE Awards(GlobeNewswire)
2024-12-10 19:00
Trupanion Named Top Employer in Six Categories at VIBE Awards(Globenewswire)
2024-12-10 19:00
DXCM: What does Argus have to say about TRUP?(Argus Research)
2024-12-04 08:00
Cold and Creaky: truInsights into How Winter Weather Impacts our Pets(GlobeNewswire)
2024-12-03 19:00
DXCM: What does Argus have to say about TRUP?(Argus Research)
2024-12-03 19:00
Cold and Creaky: truInsights into How Winter Weather Impacts our Pets(Globenewswire)
2024-12-02 15:27
Trupanion Insider Sold Shares Worth $523,789, According to a Recent SEC Filing(MT Newswires)

Page 1 of 10

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.